- Board of Directors
International Society of Dermatopathology (ISDP)
Developed by The Continuing Education Committee and approved by the ISDP Board of Directors
1. Purpose: The Continuing Medical Education mission of the International Society of Dermatopathology (ISDP) is to improve the overall quality of dermatopathology practiced by dermatopathologists, dermatologists and pathologists by offering courses that update medical knowledge essential to:
2. Content Areas: The content of educational activities encompasses a broad knowledge base, which includes new and updated diagnostic approaches in techniques and technology applicable to routine and obscure cases; practice- and systems-based learning and improvements; effective communication skills; medical knowledge of established and new, evolving cutaneous disorders that incorporates clinical, histologic, immunologic and molecular data; and the application of all of the above to patient care.
Topics covered are devoted to areas relating to our attendees, and include but are not limited to:
3. Target Audience: The ISDP offers CME activities that are primarily designed for U.S. and non-U.S. physicians who are board certified in dermatopathology. The secondary audience includes dermatologists, pathologists and physicians-in-training who practice dermatopathology. A third-tier audience includes individuals possessing a PhD, DVM, DDS, researchers, and scientists or non-physicians such as medical students and administrative staff who demonstrate special expertise in pathology of the skin or research. They have in common the goal of seeking to update their diagnostic skills and acquiring new knowledge in the rapidly evolving field of dermatopathology.
The practice settings of the target audience include university and private laboratories, medical schools and teaching hospitals, military hospitals, community hospitals not affiliated with medical schools, and private practice.
4. Types of activities: The educational activities provided in the two-day annual conference are structured into didactic courses, interactive case-based presentations, oral and poster presentations, basic science, panel discussions as components of course presentations, self-assessment courses and keynote speakers who are experts in the field of dermatopathology or allied fields
5. Expected Results: The CME Program is expected to improve physicians’ abilities and execution in diagnosing routine and obscure cutaneous diseases; written and oral communications skills; and practice management. Effectiveness of the CME program will be measured by physicians’ improved ability to: diagnose; create and/or revise protocols, policies, or procedures in the workplace; or change the management or treatment of the patients.
Some specific ways in which the learner can be considered to have realized these results are:
Assessment of the effectiveness of CME activities in improving the quality and accuracy of dermatopathologic diagnoses is largely limited to evaluation of competence and performance. Indirect methods available to the provider include course evaluations that query the extent to which the learner felt that the course provided new and useful information applicable to his/her diagnostic skills and that will significantly improve the learners diagnostic skills. A direct metric system being considered for future implementation by the provider is the use of an audience response system during a course presentation to assess the learners’ ability to absorb difficult concepts and address any misunderstandings of the subject being discussed.
The Board of Directors measures the success of the CME program annually by reviewing the administration of the CME program and utilizing aggregate response data from self-assessment tests, live audience feedback, activity evaluations and post-course surveys. Volunteers directly responsible for educational planning and execution, staff or members at large can recommend changes to the CME Program. The Board of Directors shall approve any and all changes.